Literature DB >> 940707

Intellectual deficits after transient tyrosinemia in the term neonate.

P Mamunes, P E Prince, N H Thornton, P A Hunt, E S Hitchcock.   

Abstract

In order to determine if prolonged, significant transient neonatal tyrosinemia (TNT) is injurious to the developing central nervous system, 15 term infants who had suffered from this disorder for a mean duration of 50 days underwent comprehensive psychometric evaluations at a mean (+/- 1 SD) age of 56.5 +/- 7.8 months. Their mean maximum detected tyrosine level had been 25.8 mg/dl (range, 13.6 to 42.0) and their defect was considered secondary to a combination of a high protein formula intake and a lack of supplemental vitamin C. Compared to a control group, significantly lower mean scores were obtained by the TNT group on the McCarthy Scale of Children's Abilities (77.1 vs. 92, P = .008) and the Illinois Test of Psycholinguistic Ability (92.3 vs. 109.9, P = .002). Performance scores varied inversely with the duration of TNT. Although these children are not classifiable as "mentally retarded," TNT may cause specific learning disabilities. There is, therefore, a need to determine the frequency of TNT in infants fed evaporated milk and other high-protein milk formulas and to develop ways to prevent its occurrence.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 940707

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

1.  Heterogeneity of follow-up procedures in French and Belgian patients with treated hereditary tyrosinemia type 1: results of a questionnaire and proposed guidelines.

Authors:  Manuel Schiff; Pierre Broue; Brigitte Chabrol; Corinne De Laet; Dalila Habes; Karine Mention; Jacques Sarles; Anne Spraul; Vassili Valayannopoulos; Hélène Ogier de Baulny
Journal:  J Inherit Metab Dis       Date:  2011-12-14       Impact factor: 4.982

2.  Plasma amino acid concentrations in parenterally fed preterm infants.

Authors:  D Clark; M Henderson; M Smith; P R Dear
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

3.  A clinical trial of two parenteral nutrition solutions in neonates.

Authors:  N McIntosh; V Mitchell
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

4.  Regulation of tyrosine aminotransferase in foetal rat liver.

Authors:  S M Andersson; N C Räihä; J J Ohisalo
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

5.  Tyrosine and its metabolites in urine and serum of premature and mature newborns: increased values during formula versus breast feeding.

Authors:  H J Sternowsky; K Heigl
Journal:  Eur J Pediatr       Date:  1979-11       Impact factor: 3.183

6.  Egg and breast milk based nitrogen sources compared.

Authors:  J W Puntis; P A Ball; M A Preece; A Green; G A Brown; I W Booth
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

7.  Development of tyrosine aminotransferase and para-hydroxyphenylpyruvate dioxygenase activities in fetal and neonatal human liver.

Authors:  J J Ohisalo; T Laskowska-Klita; S M Andersson
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

8.  Iatrogenic and transient hyperglycinemia in patients with phenylketonuria.

Authors:  N Nagata; S Shinozuka; I Matsuda; M Kambe; Y Tsuji
Journal:  Eur J Pediatr       Date:  1979-09       Impact factor: 3.183

9.  Hereditary tyrosinaemia type II in a consanguineous Ashkenazi Jewish family: intrafamilial variation in phenotype; absence of parental phenotype effects on the fetus.

Authors:  D Chitayat; A Balbul; V Hani; O A Mamer; C Clow; C R Scriver
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

10.  Creatine and pyruvate prevent the alterations caused by tyrosine on parameters of oxidative stress and enzyme activities of phosphoryltransfer network in cerebral cortex of Wistar rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Narielle Ferner Bonorino; Bruna May Lopes Costa; Cláudia Funchal; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Mol Neurobiol       Date:  2014-06-25       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.